Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Paunel Görgülü, Adnana ^a   Flohé, Sascha ^a   Scholz, Martin ^a   Windolf, Joachim ^a   Lögters, Tim ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIBODY; FAS ANTIGEN; INTERLEUKIN 6; LEUKOCYTE ELASTASE; PROPIDIUM IODIDE;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INJURY SEVERITY; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEPSIS;

EID: 78651326476     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9965     Document Type: Article

References (48)

1. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989, 83:865-875. 10.1172/JCI113970, 303760, 2921324.
2. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852. 10.1038/nature01320, 12490957.
3. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003, 31:S195-S199. 10.1097/01.CCM.0000057843.47705.E8, 12682440.
4. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007, 35:757-766. 10.1080/01926230701584163, 17943649.
5. Kuligowski M, Kitching A, Hickey M. Leukocyte recruitment to the inflamed glomerulus: A critical role for platelet-derived P-selectin in the absence of rolling. J Immunol 2006, 176:6991-6999.
6. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006, 368:157-169. 10.1016/S0140-6736(06)69005-3, 16829300.
7. Donnelly SC, MacGregor I, Zamani A, Gordon MW, Robertson CE, Steedman DJ, Little K, Haslett C. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995, 151:1428-1433.
8. Bhatia R, Dent C, Topley N, Pallister I. Neutrophil priming for elastase release in adult blunt trauma patients. J Trauma 2006, 60:590-596. 10.1097/01.ta.0000205614.51885.ff, 16531859.
9. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 1997, 61:375-380.
10. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995, 16:569-574. 10.1016/0167-5699(95)80079-4, 8579749.
11. Siegel RM, Chan FK, Chun HJ, Lenardo MJ. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 2000, 1:469-474. 10.1038/82712, 11101867.
12. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 1999, 33:29-55. 10.1146/annurev.genet.33.1.29, 10690403.
13. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994, 263:1759-1762. 10.1126/science.7510905, 7510905.
14. Cascino I, Fiucci G, Papoff G, Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 1995, 154:2706-2713.
15. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995, 182:1777-1783. 10.1084/jem.182.6.1777, 2192231, 7500022.
16. Song E, Chen J, Ouyang N, Su F, Wang M, Heemann U. Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer. Br J Cancer 2001, 85:1047-1054. 10.1054/bjoc.2001.2042, 2375090, 11592778.
17. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993, 364:806-809. 10.1038/364806a0, 7689176.
18. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M, Martin TR. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999, 163:2217-2225.
19. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 1996, 184:429-440. 10.1084/jem.184.2.429, 2192712, 8760796.
20. Jimenez MF, Watson RW, Parodo J, Evans D, Foster D, Steinberg M, Rotstein OD, Marshall JC. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997, 132:1263-1270.
21. Chitnis D, Dickerson C, Munster AM, Winchurch RA. Inhibition of apoptosis in polymorphonuclear neutrophils from burn patients. J Leukoc Biol 1996, 59:835-839.
22. Greenspan L, McLellan BA, Greig H. Abbreviated Injury Scale and Injury Severity Score: a scoring chart. J Trauma 1985, 25:60-64. 10.1097/00005373-198501000-00010, 3965737.
23. Calandra T, Cohen J, . International Sepsis Forum Definition of Infection in the ICU Consensus Conference The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005, 33:1538-1548. 10.1097/01.CCM.0000168253.91200.83, 16003060, International Sepsis Forum Definition of Infection in the ICU Consensus Conference.
24. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple Organ Dysfunction Score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652. 10.1097/00003246-199510000-00007, 7587228.
25. Maianski NA, Mul FP, van Buul JD, Roos D, Kuijpers TW. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood 2002, 99:672-679. 10.1182/blood.V99.2.672, 11781253.
26. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991, 139:271-279. 10.1016/0022-1759(91)90198-O, 1710634.
27. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
28. Paunel-Görgülü A, Zörnig M, Lögters T, Altrichter J, Rabenhorst U, Cinatl J, Windolf J, Scholz M. Mcl-1-mediated Impairment of the intrinsic apoptosis pathway in circulating neutrophils from critically ill patients can be overcome by Fas stimulation. J Immunol 2009, 183:6198-6206.
29. Maianski NA, Maianski AN, Kujpers TW, Roos D. Apoptosis of neutrophils. Acta Haematol 2004, 111:56-66. 10.1159/000074486, 14646345.
30. Tilton B, Andjelkovic M, Didichenko SA, Hemmings BA, Thelen M. G-Protein-coupled receptors and Fcγ-receptors mediate activation of Akt/protein kinase B in human phagocytes. J Biol Chem 1997, 272:28096-28101. 10.1074/jbc.272.44.28096, 9346964.
31. McLeish KR, Knall C, Ward RA, Gerwins P, Coxon PY, Klein JB, Johnson GL. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-α and GM-CSF. J Leukoc Biol 1998, 64:537-545.
32. Derouet M, Thomas L, Cross A, Moots RJ, Edwards SW. Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem 2004, 279:26915-26921. 10.1074/jbc.M313875200, 15078892.
33. Papathanassoglou ED, Moynihan JA, Vermillion DL, McDermott MP, Ackerman MH. Soluble fas levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients. Shock 2000, 14:107-112. 10.1097/00024382-200014020-00005, 10947151.
34. Marsik C, Halama T, Cardona F, Wlassits W, Mayr F, Pleiner J, Jilma B. Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans. Shock 2003, 20:493-496. 10.1097/01.shk.0000097248.97298.ea, 14625471.
35. Torre D, Tambini R, Manfredi M, Mangani V, Livi P, Maldifassi V, Campi P, Speranza F. Circulating levels of FAS/APO-1 in patients with the systemic inflammatory response syndrome. Diagn Microbiol Infect Dis 2003, 45:233-236. 10.1016/S0732-8893(02)00550-3, 12729991.
36. De Freitas I, Fernandez-Somoza M, Essenfeld-Sekler, Cardier JE. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-α/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest 2004, 125:2238-2246. 10.1378/chest.125.6.2238, 15189947.
37. Mitani K, Nishioka Y, Yamabe K, Ogawa H, Miki T, Yanagawa H, Sone S. Soluble Fas in malignant pleural effusion and its expression in lung cancer cells. Cancer Sci 2003, 94:302-307. 10.1111/j.1349-7006.2003.tb01437.x, 12824926.
38. Lee KS, Choi YH, Kim YS, Baik SH, Oh YJ, Sheen SS, Park JH, Hwang SC, Park KJ. Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respir Med 2008, 102:464-469. 10.1016/j.rmed.2007.10.001, 17988850.
39. Iwase M, Kondo G, Watanabe H, Takaoka S, Uchida M, Ohashi M, Nagumo M. Regulation of Fas-mediated apoptosis in neutrophils after surgery-induced acute inflammation. J Surg Res 2006, 134:114-123. 10.1016/j.jss.2005.10.013, 16376940.
40. Liacos C, Katsaragakis S, Konstadoulakis MM, Messaris EG, Papanicolaou M, Georgiadis GG, Menenakos E, Vasiliadi-Chioti A, Androulakis G. Apoptosis in cells of bronchoalveolar lavage: a cellular reaction in patients who die with sepsis and respiratory failure. Crit Care Med 2001, 29:2310-2317. 10.1097/00003246-200112000-00013, 11801832.
41. Fialkow L, Fochesatto Filho L, Bozzetti MC, Milani AR, Rodrigues Filho EM, Ladniuk RM, Pierozan P, de Moura RM, Prolla JC, Vachon E, Downey GP. Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit Care 2006, 10:R155. 10.1186/cc5090, 1794458, 17092345.
42. Silvestris F, Grinello D, Tucci M, Cafforio P, Dammacco F. Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus. Lupus 2003, 12:8-14. 10.1191/0961203303lu250oa, 12587820.
43. Ma Y, Ye F, Lv W, Cheng Q, Chen H, Xie X. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma. Eur J Obstet Gynaecol Reprod Biol 2008, 138:204-211.
44. Choudhry MA, Ahmad S, Thompson KD, Sayeed MM. T-lymphocyte Ca2+ signalling and proliferative responses during sepsis. Shock 1994, 1:466-471. 10.1097/00024382-199406000-00012, 7735977.
45. Roth G, Moser B, Krenn C, Brunner M, Haisjackl M, Almer G, Gerlitz S, Wolner E, Boltz-Nitulescu G, Ankersmit HJ. Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun 2003, 308:840-846. 10.1016/S0006-291X(03)01482-7, 12927795.
46. Dudziak D, Nimmerjahn F, Bornkamm GW, Laux G. Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation. J Immunol 2005, 174:6672-6676.
47. Munder M, Schneider H, Luckner C, Giese T, Langhans CD, Fuentes JM, Kropf P, Mueller I, Kolb A, Modolell M, Ho AD. Suppression of T-cell functions by human granulocyte arginase. Blood 2006, 108:1627-1634. 10.1182/blood-2006-11-010389, 16709924.
48. Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kübler H, Yancey D, Dahm P, Vieweg J. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res 2008, 14:8270-8278. 10.1158/1078-0432.CCR-08-0165, 19088044.